0002032849-26-000002.txt : 20261015 0002032849-26-000002.hdr.sgml : 20261015 20261015164710 ACCESSION NUMBER: 0002032849-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261015 DATE AS OF CHANGE: 20261015 EFFECTIVENESS DATE: 20261015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensho Therapeutics, Inc. CENTRAL INDEX KEY: 0002032849 ORGANIZATION NAME: EIN: 992570254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601479 FILM NUMBER: 261463530 BUSINESS ADDRESS: STREET 1: 422 MOUNTAIN WAY CITY: MORRIS PLAINS STATE: NY ZIP: 07950 BUSINESS PHONE: 973-241-3669 MAIL ADDRESS: STREET 1: 422 MOUNTAIN WAY CITY: MORRIS PLAINS STATE: NY ZIP: 07950 D 1 primary_doc.xml X0708 D LIVE 0002032849 Ensho Therapeutics, Inc. 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 973-475-8970 DELAWARE None None Corporation true 2024 Danielle Fry 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Executive Officer Arash Rassoulpour 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Carlos Solorzano 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Eric Pham 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Gerhard Hagn 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Neena Bitritto-Garg 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Tariq Kassum 50 Tice Boulevard Suite 340 - #1005 Woodcliff Lake NJ NEW JERSEY 07677 Director Biotechnology Decline to Disclose 06b false 2026-10-02 false true true false 1 15604179 7281948 8322231 false 7 0 0 0 false Ensho Therapeutics, Inc. /s/ Danielle Fry Danielle Fry Chief Legal Officer & Chief Operating Officer 2026-10-15